KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Sales and Divestitures (2017 - 2025)

Fulgent Genetics' Gains from Sales and Divestitures history spans 9 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 4.48% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 4.48%, while the annual FY2025 figure was $1.0 million, 4.48% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $1.0 million at Fulgent Genetics, up from $1.0 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.1 million in Q4 2023 and bottomed at $699000.0 in Q4 2022.
  • The 5-year median for Gains from Sales and Divestitures is $1.0 million (2024), against an average of $930800.0.
  • The largest annual shift saw Gains from Sales and Divestitures fell 16.39% in 2022 before it skyrocketed 52.5% in 2023.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $836000.0 in 2021, then dropped by 16.39% to $699000.0 in 2022, then soared by 52.5% to $1.1 million in 2023, then fell by 5.82% to $1.0 million in 2024, then increased by 4.48% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Gains from Sales and Divestitures are $1.0 million (Q4 2025), $1.0 million (Q4 2024), and $1.1 million (Q4 2023).